BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21264452)

  • 1. Incidence, prevalence and future trends of primary basal cell carcinoma in the Netherlands.
    Flohil SC; de Vries E; Neumann HA; Coebergh JW; Nijsten T
    Acta Derm Venereol; 2011 Jan; 91(1):24-30. PubMed ID: 21264452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cumulative risks and rates of subsequent basal cell carcinomas in the Netherlands.
    Flohil SC; Koljenović S; de Haas ER; Overbeek LI; de Vries E; Nijsten T
    Br J Dermatol; 2011 Oct; 165(4):874-81. PubMed ID: 21711333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictions of skin cancer incidence in the Netherlands up to 2015.
    de Vries E; van de Poll-Franse LV; Louwman WJ; de Gruijl FR; Coebergh JW
    Br J Dermatol; 2005 Mar; 152(3):481-8. PubMed ID: 15787817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin cancer trends in Northern Ireland and consequences for provision of dermatology services.
    Hoey SE; Devereux CE; Murray L; Catney D; Gavin A; Kumar S; Donnelly D; Dolan OM
    Br J Dermatol; 2007 Jun; 156(6):1301-7. PubMed ID: 17535230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in basal cell carcinoma incidence steepest in individuals with high socioeconomic status: results of a cancer registry study in The Netherlands.
    van Hattem S; Aarts MJ; Louwman WJ; Neumann HA; Coebergh JW; Looman CW; Nijsten T; de Vries E
    Br J Dermatol; 2009 Oct; 161(4):840-5. PubMed ID: 19438849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent trends in incidence of nonmelanoma skin cancers in the East of Scotland, 1992-2003.
    Brewster DH; Bhatti LA; Inglis JH; Nairn ER; Doherty VR
    Br J Dermatol; 2007 Jun; 156(6):1295-300. PubMed ID: 17535229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-based incidence of basal cell carcinoma in a Spanish Mediterranean area.
    Bielsa I; Soria X; Esteve M; Ferrándiz C;
    Br J Dermatol; 2009 Dec; 161(6):1341-6. PubMed ID: 19796178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in the incidence of non-melanoma skin cancer in Slovakia, 1978-1995.
    Plesko I; Severi G; Obsitníková A; Boyle P
    Neoplasma; 2000; 47(3):137-42. PubMed ID: 11043834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of cancer in first-degree relatives of basal cell carcinoma patients.
    van Rossum MM; Wopereis D; Hoyer T; Soerjomataram I; Schalkwijk J; van de Kerkhof PC; Kiemeney LA; Hoogerbrugge N
    Arch Dermatol Res; 2009 Apr; 301(4):295-9. PubMed ID: 18985366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal cell carcinoma of the eyelid in Finland during 1953-97.
    Paavilainen V; Tuominen J; Pukkala E; Saari KM
    Acta Ophthalmol Scand; 2005 Apr; 83(2):215-20. PubMed ID: 15799736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonmelanoma skin carcinoma in Albuquerque, New Mexico: experience of a major health care provider.
    Hoy WE
    Cancer; 1996 Jun; 77(12):2489-95. PubMed ID: 8640697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for single and multiple basal cell carcinomas.
    Kiiski V; de Vries E; Flohil SC; Bijl MJ; Hofman A; Stricker BH; Nijsten T
    Arch Dermatol; 2010 Aug; 146(8):848-55. PubMed ID: 20713815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of eyelid cancers in Taiwan: a 21-year review.
    Lin HY; Cheng CY; Hsu WM; Kao WH; Chou P
    Ophthalmology; 2006 Nov; 113(11):2101-7. PubMed ID: 16962174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidence of basal cell carcinoma in Croatia: an epidemiological study.
    Celić D; Lipozencić J; Jurakić Toncić R; Ledić-Drvar D; Marasović D; Puizina-Ivić N; Cabrijan L; Bradamante M
    Acta Dermatovenerol Croat; 2009; 17(2):108-12. PubMed ID: 19595266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in the incidence of nonmelanoma skin cancers in southeastern Arizona, 1985-1996.
    Harris RB; Griffith K; Moon TE
    J Am Acad Dermatol; 2001 Oct; 45(4):528-36. PubMed ID: 11568742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in Basal cell carcinoma incidence rates: a 37-year Dutch observational study.
    Flohil SC; Seubring I; van Rossum MM; Coebergh JW; de Vries E; Nijsten T
    J Invest Dermatol; 2013 Apr; 133(4):913-8. PubMed ID: 23190883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid and continuous increases in incidence rates of basal cell carcinoma in the southeast Netherlands since 1973.
    de Vries E; Louwman M; Bastiaens M; de Gruijl F; Coebergh JW
    J Invest Dermatol; 2004 Oct; 123(4):634-8. PubMed ID: 15373766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in the incidence of basal cell carcinoma by histopathological subtype.
    Arits AH; Schlangen MH; Nelemans PJ; Kelleners-Smeets NW
    J Eur Acad Dermatol Venereol; 2011 May; 25(5):565-9. PubMed ID: 20840348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant melanoma and nonmelanoma skin cancers in Northrhine-Westphalia, Germany: a patient- vs. diagnosis-based incidence approach.
    Stang A; Ziegler S; Büchner U; Ziegler B; Jöckel KH; Ziegler V
    Int J Dermatol; 2007 Jun; 46(6):564-70. PubMed ID: 17550552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiologic risk factors of basal cell carcinoma development and age at onset in a Southern European population from Greece.
    Dessinioti C; Tzannis K; Sypsa V; Nikolaou V; Kypreou K; Antoniou C; Katsambas A; Stratigos AJ
    Exp Dermatol; 2011 Aug; 20(8):622-6. PubMed ID: 21521370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.